Article
Raf Kinase Inhibitor Protein Expression in a Survival Analysis of Colorectal Cancer Patients
18 Dec 2006
Abstract excerpt
PURPOSE: Raf kinase inhibitor protein (RKIP) inhibits the Raf and nuclear factor kappa B signaling pathways, and suppresses metastasis in animal models. We examined whether RKIP expression in primary colorectal cancers (CRCs) correlates with the risk of metastasis and overall survival. PATIENTS AND METHODS: RKIP expression was examined immunohistochemically in three separate cohorts: a tissue microarray...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
